glomerular hypertrophy. In addition, glomerular matrix expansion and TGF-␤ expression in cyclosporine-treated diabetic rats was reduced [8] . From this study, we concluded that calcineurin is a key player in the mesangial cell response to hyperglycaemia and that targeting of this pathway may be an effective strategy to improve and/or preserve diabetic renal function.
To investigate this possibility further, we examined the kidneys of mice lacking either ␣ or ␤ isoform of the catalytic subunit of calcineurin. Interestingly, we found that loss of the ␣ isoform resulted in increased matrix expansion and renal dysfunction [9] . In vitro, loss of the ␣ isoform had no effect on NFATc whereas loss of the ␤ completely abrogated NFATc transcriptional activity and nuclear localization [7] . Loss 
Materials and methods

Animal models
Calcineurin A-␤ knockout (␤ -/-) mice and transgenic NFATc-luciferase
(NFATc-luc) reporter mice were created by J. Molkentin (Cincinnati Children's Hospital, Cincinnati, OH, USA) as described previously and were kindly gifted to our laboratory [10, 11] . All 
Calcineurin phosphatase assay
Calcineurin phosphatase activity was determined as described [12] . 
Western blots
␤-null and wild-type fibroblasts were previously described [7] . (Fig. 7C ). [3, 4, [17] [18] [19] . More specifically, mice lacking the ␤ isoform fail to mount a cardiac hypertrophic response following aortic banding [20] . [13, 21] . The remaining activity in the ␤ -/-sections is attributable, therefore, to the ␣ isoform which has been described to be expressed predominantly in the cortex and OM [13, 21] [19, [23] [24] [25] [26] and skeletal muscle cell hypertrophy [3, 4] . Analyses of signalling pathways involved in these responses identified a requirement for transcriptional mediators including NFATs [19] . A particular role for the ␤ isoform has also been described by Bueno et al. who reported that ␤-null mice have an impaired cardiac hypertrophic response [20] . Previously, we found that inhibition of calcineurin with cyclosporine reduced whole kidney hypertrophy and completely blocked glomerular hypertrophy in diabetic rats [8] . Consistent 
Results
Induction of diabetes and renal changes
Fig. 4 Expression of glomerular fibronectin and TGF-␤ are not reduced with loss of CnA␤. (A) Fibronectin expression in control and diabetic wild-type (i, ii) and ␤ -/-mice (iii, iv) was determined by immunofluorescence using Cy3-conjugated secondary antibody to detect antifibronectin antibodies. (B) Results from four to six mice per group were then semi-quantitated and graphed. *P Ͻ 0.05, two-way ANOVA. (C) TGF-␤ expression in control and diabetic wild-type (i, ii) and CnA ␤ -/-mice (iii, iv) was determined by immunofluorescence using fluoroscein isothiocyanate (FITC)-conjugated secondary antibody to detect anti-TGF-␤ antibodies. (D) Results
Discussion
The role of calcineurin in the kidney is an area of growing scientific interest and clinical relevance. Inhibition of calcineurin with cyclosporine and Tacrolimus frequently result in nephrotoxicity
. However, it is interesting that the site of highest ␤ activity appears to be the IM whereas the region most substantially affected by loss of ␤ in the diabetic kidney is the cortex -the primary portion of the kidney generally responsible for compensatory hypertrophy. The most likely explanation for this is that
